JP5728135B2 - 凍結乾燥粒子製造用プロセスライン - Google Patents
凍結乾燥粒子製造用プロセスライン Download PDFInfo
- Publication number
- JP5728135B2 JP5728135B2 JP2014533796A JP2014533796A JP5728135B2 JP 5728135 B2 JP5728135 B2 JP 5728135B2 JP 2014533796 A JP2014533796 A JP 2014533796A JP 2014533796 A JP2014533796 A JP 2014533796A JP 5728135 B2 JP5728135 B2 JP 5728135B2
- Authority
- JP
- Japan
- Prior art keywords
- process line
- particles
- product
- lyophilizer
- freeze
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims description 418
- 230000008569 process Effects 0.000 title claims description 397
- 239000002245 particle Substances 0.000 title claims description 104
- 238000004519 manufacturing process Methods 0.000 title claims description 40
- 238000012546 transfer Methods 0.000 claims description 198
- 230000001954 sterilising effect Effects 0.000 claims description 82
- 238000004659 sterilization and disinfection Methods 0.000 claims description 77
- 239000007788 liquid Substances 0.000 claims description 74
- 239000007921 spray Substances 0.000 claims description 59
- 238000012545 processing Methods 0.000 claims description 54
- 238000004108 freeze drying Methods 0.000 claims description 40
- 239000000427 antigen Substances 0.000 claims description 38
- 102000036639 antigens Human genes 0.000 claims description 38
- 108091007433 antigens Proteins 0.000 claims description 38
- 238000001816 cooling Methods 0.000 claims description 37
- 239000000203 mixture Substances 0.000 claims description 36
- 238000004140 cleaning Methods 0.000 claims description 34
- 238000007710 freezing Methods 0.000 claims description 30
- 230000008014 freezing Effects 0.000 claims description 30
- 238000011049 filling Methods 0.000 claims description 29
- 239000002671 adjuvant Substances 0.000 claims description 27
- 239000008364 bulk solution Substances 0.000 claims description 18
- 230000036512 infertility Effects 0.000 claims description 17
- 229960005486 vaccine Drugs 0.000 claims description 16
- 238000005192 partition Methods 0.000 claims description 13
- 238000005406 washing Methods 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 6
- 238000005345 coagulation Methods 0.000 claims description 5
- 239000012752 auxiliary agent Substances 0.000 claims description 3
- 230000015271 coagulation Effects 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- 239000000047 product Substances 0.000 description 172
- 239000008188 pellet Substances 0.000 description 46
- 238000001035 drying Methods 0.000 description 28
- 238000003860 storage Methods 0.000 description 27
- 238000000926 separation method Methods 0.000 description 25
- 239000002826 coolant Substances 0.000 description 17
- 238000005469 granulation Methods 0.000 description 17
- 230000003179 granulation Effects 0.000 description 17
- 239000000463 material Substances 0.000 description 17
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 16
- 230000032258 transport Effects 0.000 description 15
- 230000007246 mechanism Effects 0.000 description 13
- 239000008186 active pharmaceutical agent Substances 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 230000006870 function Effects 0.000 description 11
- 239000003814 drug Substances 0.000 description 10
- 230000005484 gravity Effects 0.000 description 10
- 239000002609 medium Substances 0.000 description 10
- 238000013459 approach Methods 0.000 description 9
- 238000012423 maintenance Methods 0.000 description 8
- 229910052757 nitrogen Inorganic materials 0.000 description 8
- 230000009969 flowable effect Effects 0.000 description 7
- 239000007789 gas Substances 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 241000700605 Viruses Species 0.000 description 6
- 230000000875 corresponding effect Effects 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 239000011859 microparticle Substances 0.000 description 6
- 238000000859 sublimation Methods 0.000 description 6
- 230000008022 sublimation Effects 0.000 description 6
- 238000001514 detection method Methods 0.000 description 5
- 239000010419 fine particle Substances 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- 238000004886 process control Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000000889 atomisation Methods 0.000 description 4
- 229960000074 biopharmaceutical Drugs 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 238000012432 intermediate storage Methods 0.000 description 4
- 238000012792 lyophilization process Methods 0.000 description 4
- 239000002105 nanoparticle Substances 0.000 description 4
- 239000008184 oral solid dosage form Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 238000005507 spraying Methods 0.000 description 4
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 102000002689 Toll-like receptor Human genes 0.000 description 3
- 108020000411 Toll-like receptor Proteins 0.000 description 3
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 239000000556 agonist Substances 0.000 description 3
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000007599 discharging Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000002502 liposome Substances 0.000 description 3
- 229920001542 oligosaccharide Polymers 0.000 description 3
- 150000002482 oligosaccharides Chemical class 0.000 description 3
- -1 other injectables Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 150000005846 sugar alcohols Chemical class 0.000 description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- 229910002706 AlOOH Inorganic materials 0.000 description 2
- 229910017119 AlPO Inorganic materials 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- 241000725619 Dengue virus Species 0.000 description 2
- 241000710831 Flavivirus Species 0.000 description 2
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 2
- 101000831567 Homo sapiens Toll-like receptor 2 Proteins 0.000 description 2
- 101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 102100024333 Toll-like receptor 2 Human genes 0.000 description 2
- 102100039360 Toll-like receptor 4 Human genes 0.000 description 2
- 208000003152 Yellow Fever Diseases 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 230000002238 attenuated effect Effects 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000007919 dispersible tablet Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000005429 filling process Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000012847 fine chemical Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 239000000693 micelle Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- UNEIHNMKASENIG-UHFFFAOYSA-N para-chlorophenylpiperazine Chemical compound C1=CC(Cl)=CC=C1N1CCNCC1 UNEIHNMKASENIG-UHFFFAOYSA-N 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- SGNXVBOIDPPRJJ-PSASIEDQSA-N 1-[(1r,6r)-9-azabicyclo[4.2.1]non-4-en-5-yl]ethanone Chemical compound CC(=O)C1=CCC[C@@H]2CC[C@H]1N2 SGNXVBOIDPPRJJ-PSASIEDQSA-N 0.000 description 1
- KSXTUUUQYQYKCR-LQDDAWAPSA-M 2,3-bis[[(z)-octadec-9-enoyl]oxy]propyl-trimethylazanium;chloride Chemical compound [Cl-].CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C[N+](C)(C)C)OC(=O)CCCCCCC\C=C/CCCCCCCC KSXTUUUQYQYKCR-LQDDAWAPSA-M 0.000 description 1
- 108010042708 Acetylmuramyl-Alanyl-Isoglutamine Proteins 0.000 description 1
- 108010077805 Bacterial Proteins Proteins 0.000 description 1
- 241000588832 Bordetella pertussis Species 0.000 description 1
- 108010039939 Cell Wall Skeleton Proteins 0.000 description 1
- 241000193163 Clostridioides difficile Species 0.000 description 1
- 241000193155 Clostridium botulinum Species 0.000 description 1
- 241000759568 Corixa Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108010040721 Flagellin Proteins 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 241000709721 Hepatovirus A Species 0.000 description 1
- 101000831496 Homo sapiens Toll-like receptor 3 Proteins 0.000 description 1
- 101000669460 Homo sapiens Toll-like receptor 5 Proteins 0.000 description 1
- 101000669402 Homo sapiens Toll-like receptor 7 Proteins 0.000 description 1
- 101000800483 Homo sapiens Toll-like receptor 8 Proteins 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 241000710842 Japanese encephalitis virus Species 0.000 description 1
- 108010028921 Lipopeptides Proteins 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- 108010038988 Peptide Hormones Proteins 0.000 description 1
- 102000015731 Peptide Hormones Human genes 0.000 description 1
- 208000034809 Product contamination Diseases 0.000 description 1
- 241000711798 Rabies lyssavirus Species 0.000 description 1
- 241000702670 Rotavirus Species 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 108010060818 Toll-Like Receptor 9 Proteins 0.000 description 1
- 102100024324 Toll-like receptor 3 Human genes 0.000 description 1
- 102100039357 Toll-like receptor 5 Human genes 0.000 description 1
- 102100039390 Toll-like receptor 7 Human genes 0.000 description 1
- 102100033110 Toll-like receptor 8 Human genes 0.000 description 1
- 102100033117 Toll-like receptor 9 Human genes 0.000 description 1
- HIHOWBSBBDRPDW-PTHRTHQKSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] n-[2-(dimethylamino)ethyl]carbamate Chemical compound C1C=C2C[C@@H](OC(=O)NCCN(C)C)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HIHOWBSBBDRPDW-PTHRTHQKSA-N 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 description 1
- 239000003948 anatoxin Substances 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 210000004520 cell wall skeleton Anatomy 0.000 description 1
- SQQXRXKYTKFFSM-UHFFFAOYSA-N chembl1992147 Chemical compound OC1=C(OC)C(OC)=CC=C1C1=C(C)C(C(O)=O)=NC(C=2N=C3C4=NC(C)(C)N=C4C(OC)=C(O)C3=CC=2)=C1N SQQXRXKYTKFFSM-UHFFFAOYSA-N 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000000112 cooling gas Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000010259 detection of temperature stimulus Effects 0.000 description 1
- UMGXUWVIJIQANV-UHFFFAOYSA-M didecyl(dimethyl)azanium;bromide Chemical compound [Br-].CCCCCCCCCC[N+](C)(C)CCCCCCCCCC UMGXUWVIJIQANV-UHFFFAOYSA-M 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000005496 eutectics Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000013020 final formulation Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000012595 freezing medium Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 229940045808 haemophilus influenzae type b Drugs 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 229940124669 imidazoquinoline Drugs 0.000 description 1
- 229940124541 immunological agent Drugs 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- BSOQXXWZTUDTEL-ZUYCGGNHSA-N muramyl dipeptide Chemical compound OC(=O)CC[C@H](C(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@@H](O)[C@@H]1NC(C)=O BSOQXXWZTUDTEL-ZUYCGGNHSA-N 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000005453 pelletization Methods 0.000 description 1
- 239000000813 peptide hormone Substances 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
- 238000009428 plumbing Methods 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 238000009516 primary packaging Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000009781 safety test method Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000003566 sealing material Substances 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000012027 sterile manufacturing Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000003206 sterilizing agent Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000007723 transport mechanism Effects 0.000 description 1
- XETCRXVKJHBPMK-MJSODCSWSA-N trehalose 6,6'-dimycolate Chemical compound C([C@@H]1[C@H]([C@H](O)[C@@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](COC(=O)C(CCCCCCCCCCC3C(C3)CCCCCCCCCCCCCCCCCC)C(O)CCCCCCCCCCCCCCCCCCCCCCCCC)O2)O)O1)O)OC(=O)C(C(O)CCCCCCCCCCCCCCCCCCCCCCCCC)CCCCCCCCCCC1CC1CCCCCCCCCCCCCCCCCC XETCRXVKJHBPMK-MJSODCSWSA-N 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000000277 virosome Substances 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Images
Classifications
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F26—DRYING
- F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
- F26B5/00—Drying solid materials or objects by processes not involving the application of heat
- F26B5/04—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum
- F26B5/06—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum the process involving freezing
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F26—DRYING
- F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
- F26B5/00—Drying solid materials or objects by processes not involving the application of heat
- F26B5/04—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum
- F26B5/06—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum the process involving freezing
- F26B5/065—Drying solid materials or objects by processes not involving the application of heat by evaporation or sublimation of moisture under reduced pressure, e.g. in a vacuum the process involving freezing the product to be freeze-dried being sprayed, dispersed or pulverised
Landscapes
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Mechanical Engineering (AREA)
- General Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Drying Of Solid Materials (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Vaporization, Distillation, Condensation, Sublimation, And Cold Traps (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
- Oxygen, Ozone, And Oxides In General (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11008057.9 | 2011-10-05 | ||
| EP11008057.9A EP2578974A1 (en) | 2011-10-05 | 2011-10-05 | Process line for the production of freeze-dried particles |
| PCT/EP2012/004168 WO2013050162A1 (en) | 2011-10-05 | 2012-10-04 | Process line for the production of freeze-dried particles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014530061A JP2014530061A (ja) | 2014-11-17 |
| JP5728135B2 true JP5728135B2 (ja) | 2015-06-03 |
Family
ID=46980888
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014533796A Active JP5728135B2 (ja) | 2011-10-05 | 2012-10-04 | 凍結乾燥粒子製造用プロセスライン |
| JP2014533792A Active JP5766361B2 (ja) | 2011-10-05 | 2012-10-04 | 凍結乾燥粒子の製造用工程ライン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014533792A Active JP5766361B2 (ja) | 2011-10-05 | 2012-10-04 | 凍結乾燥粒子の製造用工程ライン |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US9920989B2 (enExample) |
| EP (4) | EP2578974A1 (enExample) |
| JP (2) | JP5728135B2 (enExample) |
| KR (2) | KR101512608B1 (enExample) |
| CN (2) | CN103917842B (enExample) |
| AU (2) | AU2012320854B2 (enExample) |
| BR (2) | BR112014007862B1 (enExample) |
| CA (2) | CA2849802C (enExample) |
| CO (2) | CO6930351A2 (enExample) |
| CR (2) | CR20140159A (enExample) |
| DK (2) | DK2764309T3 (enExample) |
| EA (2) | EA027630B1 (enExample) |
| ES (2) | ES2608478T3 (enExample) |
| HU (2) | HUE029973T2 (enExample) |
| IL (2) | IL231853A0 (enExample) |
| IN (2) | IN2014CN02407A (enExample) |
| MX (2) | MX341894B (enExample) |
| MY (2) | MY151369A (enExample) |
| PE (2) | PE20141979A1 (enExample) |
| PH (2) | PH12014500617A1 (enExample) |
| PL (2) | PL2764309T3 (enExample) |
| SG (2) | SG11201400641QA (enExample) |
| UA (2) | UA111858C2 (enExample) |
| WO (2) | WO2013050162A1 (enExample) |
| ZA (1) | ZA201401930B (enExample) |
Families Citing this family (55)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2416790B1 (en) | 2009-04-09 | 2018-05-23 | Entegrion, Inc. | Spray-dried blood products and methods of making same |
| US20110142885A1 (en) | 2009-09-16 | 2011-06-16 | Velico Medical, Inc. | Spray-dried human plasma |
| US20140083628A1 (en) | 2012-09-27 | 2014-03-27 | Velico Medical, Inc. | Spray drier assembly for automated spray drying |
| EP2578974A1 (en) | 2011-10-05 | 2013-04-10 | Sanofi Pasteur Sa | Process line for the production of freeze-dried particles |
| EP2578975A1 (en) | 2011-10-05 | 2013-04-10 | Sanofi Pasteur Sa | Rotary drum freeze-dryer |
| EP2578976A1 (en) | 2011-10-06 | 2013-04-10 | Sanofi Pasteur Sa | Rotary drum for use in a vacuum freeze-dryer |
| UA111631C2 (uk) | 2011-10-06 | 2016-05-25 | Санофі Пастер Са | Нагрівальний пристрій для роторної барабанної ліофільної сушарки |
| WO2014190992A1 (en) | 2013-05-29 | 2014-12-04 | Gea Process Engineering A/S | Method of providing inline sterile freeze drying of a product in trays accommodated in a trolley, system for carrying out the method, and use of the method |
| JP6166006B1 (ja) * | 2014-07-21 | 2017-07-19 | サノフィ パスツール エスエー | 液滴生成のための液体供給装置 |
| US9561184B2 (en) | 2014-09-19 | 2017-02-07 | Velico Medical, Inc. | Methods and systems for multi-stage drying of plasma |
| DE102015105375B4 (de) * | 2015-01-07 | 2016-11-03 | Richard Süverkrüp | Vorrichtung und Verfahren zur Erzeugung monodisperser gefrorener Tropfen |
| US9739532B2 (en) * | 2015-02-04 | 2017-08-22 | Steven F. Baugh | Botanical freeze drying system and method |
| US10465985B2 (en) | 2015-06-01 | 2019-11-05 | Ima Life North America Inc. | Bulk freeze drying using spray freezing and agitated drying with dielectric heating |
| RU2615553C1 (ru) * | 2015-10-15 | 2017-04-05 | Акционерное общество "Военно-промышленная корпорация "Научно-производственное объединение машиностроения" | Способ и устройство непрерывной сублимационной сушки жидких продуктов |
| EP3167877A1 (en) | 2015-11-12 | 2017-05-17 | Bayer Pharma Aktiengesellschaft | Method for the production of freeze-dried pellets comprising factor viii |
| CN106705574A (zh) * | 2015-11-17 | 2017-05-24 | 上海东富龙科技股份有限公司 | 一种固体制剂制造设备和方法 |
| JP6666535B2 (ja) * | 2016-01-05 | 2020-03-18 | 株式会社あい・あいエナジーアソシエイツ | 液体の凍結乾燥装置及び凍結乾燥方法 |
| CN105674691B (zh) * | 2016-04-01 | 2017-11-21 | 苏州大学 | 用于收集喷雾冷冻冰球颗粒的双密封式设备及其收集方法 |
| US10369077B2 (en) * | 2017-05-31 | 2019-08-06 | Adienne Pharma & Biotech Sa | Multi chamber flexible bag and methods of using the same |
| US10507165B2 (en) | 2017-05-31 | 2019-12-17 | Adienne Pharma & Biotech Sa | Multi chamber flexible bag and methods of using same |
| DE102017119649A1 (de) | 2017-08-28 | 2019-02-28 | Richard Süverkrüp | Verfahren zur kontinuierlichen Herstellung gefriergetrockneter Tropfen in einem geschlossenen Gaskreislauf |
| ES2779023T3 (es) * | 2017-10-20 | 2020-08-13 | Martin Christ Gefriertrocknungsanlagen Gmbh | Procedimiento para la determinación a base de presión de un parámetro de producto en un liofilizador, liofilizador y producto de software |
| KR102450460B1 (ko) * | 2017-12-29 | 2022-09-30 | 아주대학교산학협력단 | 초음파 분무기를 이용한 미립구 약제의 양산 시스템 |
| JP7038435B2 (ja) * | 2018-03-13 | 2022-03-18 | 株式会社プリス | 噴霧凍結造粒乾燥粉体製造装置及び噴霧凍結造粒乾燥粉体製造システム |
| CN111065874B (zh) * | 2018-06-08 | 2020-12-29 | 株式会社爱发科 | 真空冻结干燥装置和真空冻结干燥方法 |
| CA3105256A1 (en) | 2018-07-05 | 2020-01-09 | Bayer Aktiengesellschaft | Novel stable high-concentration formulation for anti-fxia antibodies |
| EP3864359B1 (en) | 2018-10-11 | 2023-06-28 | IMA Life North America Inc. | Bulk freeze drying system |
| WO2020161863A1 (ja) * | 2019-02-07 | 2020-08-13 | 株式会社アルバック | 真空凍結乾燥方法及び真空凍結乾燥装置 |
| US11243029B2 (en) * | 2019-04-26 | 2022-02-08 | Purdue Research Foundation | Process monitoring and control for lyophilization using a wireless sensor network |
| CN111207564B (zh) * | 2019-09-30 | 2022-01-04 | 中国科学院上海硅酸盐研究所 | 一种冷冻干燥系统及方法 |
| JP7626766B2 (ja) * | 2019-12-09 | 2025-02-04 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | 飲料ペースト |
| JP6777350B1 (ja) | 2020-05-18 | 2020-10-28 | 株式会社エムアイアイ | 真空凍結乾燥装置及び真空凍結乾燥方法 |
| TWI860477B (zh) | 2020-05-18 | 2024-11-01 | 日商Ｍｉｉ股份有限公司 | 真空凍結乾燥裝置及真空凍結乾燥方法 |
| JP6887050B1 (ja) * | 2020-08-07 | 2021-06-16 | 株式会社アルバック | 真空凍結乾燥方法および真空凍結乾燥装置 |
| CN115917232A (zh) * | 2020-08-07 | 2023-04-04 | 株式会社爱发科 | 真空冻结干燥方法、用于真空冻结干燥装置的喷射喷嘴以及真空冻结干燥装置 |
| US11874060B2 (en) | 2020-11-16 | 2024-01-16 | Sublime Stericeuticals Corporation | Continuous throughput lyophilizer-powder filler within a sterile boundary |
| CN116648300A (zh) * | 2020-12-11 | 2023-08-25 | 默沙东有限责任公司 | 用于隔离、加工和包装医药产品的紧凑型密闭系统 |
| JP7085088B1 (ja) | 2021-08-03 | 2022-06-16 | 株式会社エムアイアイ | 凍結乾燥物 |
| CN113701457A (zh) * | 2021-09-18 | 2021-11-26 | 楚天科技股份有限公司 | 一种冻干系统及冻干方法 |
| CN118302155A (zh) | 2021-10-05 | 2024-07-05 | 赛诺菲 | 用于冷冻和冷冻干燥脂质纳米颗粒（lnp）的方法及其获得的lnp |
| US12085337B2 (en) * | 2021-10-20 | 2024-09-10 | DSM Sales & Manufacturing, Inc. | Freeze-drying systems and methods |
| CN114192067A (zh) * | 2021-12-08 | 2022-03-18 | 南通东概念新材料有限公司 | 一种喷雾干燥、液氮速冻、真空冷冻干燥制备颗粒的方法 |
| US12454789B2 (en) | 2022-03-16 | 2025-10-28 | Haier Us Appliance Solutions, Inc. | Dryer appliance and method for cleaning operation |
| TW202417038A (zh) | 2022-06-15 | 2024-05-01 | 法商賽諾菲公司 | 高度濃縮的抗體組成物 |
| US11998861B2 (en) | 2022-09-15 | 2024-06-04 | Velico Medical, Inc. | Usability of a disposable for a spray drying plasma system |
| US11841189B1 (en) | 2022-09-15 | 2023-12-12 | Velico Medical, Inc. | Disposable for a spray drying system |
| US12083447B2 (en) | 2022-09-15 | 2024-09-10 | Velico Medical, Inc. | Alignment of a disposable for a spray drying plasma system |
| US12246093B2 (en) | 2022-09-15 | 2025-03-11 | Velico Medical, Inc. | Methods for making spray dried plasma |
| US11975274B2 (en) | 2022-09-15 | 2024-05-07 | Velico Medical, Inc. | Blood plasma product |
| WO2024059770A1 (en) | 2022-09-15 | 2024-03-21 | Velico Medical, Inc. | Rapid spray drying system |
| US12246266B2 (en) | 2022-09-15 | 2025-03-11 | Velico Medical, Inc. | Disposable for a spray drying system |
| WO2024184725A1 (en) * | 2023-03-03 | 2024-09-12 | Pfizer Inc. | Systems and methods for reducing electrostatic force in dynamic freeze drying |
| WO2024184721A1 (en) * | 2023-03-03 | 2024-09-12 | Pfizer Inc. | Systems and methods for pre-conditioning frozen bulk in dynamic bulk freeze drying |
| GB202402626D0 (en) * | 2024-02-23 | 2024-04-10 | Ttp Plc | Spray freeze drying formation of dry powder compositions |
| CN120926693B (zh) * | 2025-10-11 | 2026-01-02 | 天津凯莱英医药科技发展有限公司 | 喷雾冷冻干燥系统 |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2388917A (en) * | 1941-10-13 | 1945-11-13 | Hormel & Co Geo A | Process for preservation of biological materials and products resulting therefrom |
| FR1378749A (fr) | 1964-01-07 | 1964-11-13 | Leybold Hochvakuum Anlagen | Procédé et dispositif de séchage par congélation |
| US3303578A (en) | 1964-07-29 | 1967-02-14 | William C Rockwell | Continuous freeze-drying apparatus |
| US3601901A (en) | 1969-09-12 | 1971-08-31 | Earl L Rader | Freeze drying apparatus with removable conveyor and heater structures |
| US3621587A (en) | 1970-08-06 | 1971-11-23 | Smitherm Industries | Freeze drying apparatus |
| US4033048A (en) | 1976-01-12 | 1977-07-05 | Clayton Van Ike | Freeze drying apparatus |
| JPS5844703Y2 (ja) | 1979-02-01 | 1983-10-11 | クラリオン株式会社 | スピ−カの取付構造 |
| JPS55112980A (en) * | 1979-02-26 | 1980-09-01 | Nippon Oxygen Co Ltd | Freezing drier |
| DE3105623A1 (de) | 1981-02-16 | 1982-09-02 | Erhard Dipl.-Ing.agr. 8000 München Grolitsch | Verfahren zur schonenden gefriertrocknung und pulverisierung von empfindlichen trocknungsguetern wie wasserhaltigen lebensmitteln |
| AU650045B2 (en) | 1990-09-12 | 1994-06-09 | Lifecell Corporation | Method and apparatus for cryopreparation dry stabilization and rehydration of biological suspensions |
| DE4113512C2 (de) * | 1991-04-25 | 1995-04-20 | Grolitsch Lisbeth | Verfahren und Vorrichtung zur Gefriertrocknung und Pulverisierung von Lebensmitteln |
| US5230162A (en) * | 1992-06-26 | 1993-07-27 | Oyler Jr James R | Systems and methods for the deliquification of liquid-containing substances by flash sublimation |
| GB9416582D0 (en) | 1994-08-17 | 1994-10-19 | Ici Plc | Process for the production of exothermically reacting compositions |
| AU699042B2 (en) | 1995-03-09 | 1998-11-19 | Boc Group, Inc., The | Transfer port system |
| JPH0971536A (ja) | 1995-07-03 | 1997-03-18 | Nippon Telegr & Teleph Corp <Ntt> | 生物細胞含有液凍結乾燥装置 |
| DE19654134C2 (de) | 1996-04-25 | 2003-08-07 | Messer Griesheim Gmbh | Verfahren und Einrichtung zum Gefriertrocknen |
| JP3639783B2 (ja) | 2000-10-30 | 2005-04-20 | 共和真空技術株式会社 | 食品・薬品等の凍結乾燥方法および凍結乾燥装置 |
| GB0103620D0 (en) * | 2001-02-14 | 2001-03-28 | Prometic Biosciences Ltd | Sterile composition and its preparation |
| US6543155B2 (en) | 2001-03-01 | 2003-04-08 | National Agricultural Research Organization | Freeze-dried product and process and apparatus for producing it |
| JP3686594B2 (ja) | 2001-06-14 | 2005-08-24 | 共和真空技術株式会社 | 食品・薬品類の凍結乾燥装置における液材料の分注装置 |
| CN1287770C (zh) | 2001-11-19 | 2006-12-06 | 贝克顿迪肯森公司 | 颗粒型的药物组合物 |
| JP3942093B2 (ja) | 2003-01-28 | 2007-07-11 | 株式会社アルバック | 噴霧式真空凍結乾燥装置 |
| FR2862306B1 (fr) | 2003-11-17 | 2008-05-30 | Aventis Pasteur | Composition vaccinale |
| DE102004005660A1 (de) | 2004-02-04 | 2005-08-25 | Rheinische Friedrich-Wilhelms-Universität Bonn | Verfahren und Vorrichtung zur Herstellung eines lyophilisierten pharmazeutischen Materials |
| SE526792C2 (sv) * | 2004-03-03 | 2005-11-08 | Tetra Laval Holdings & Finance | Anordning för evaporativ kylning av en vätskeformig produkt |
| KR20070047239A (ko) | 2004-05-01 | 2007-05-04 | 애그리서치 리미티드 | 건조 방법 및 장치 |
| WO2006008006A1 (en) | 2004-07-23 | 2006-01-26 | Bayer Technology Services Gmbh | Sterile freezing, drying, storing, assaying and filling process (sfd-saf process) (pellet freeze-drying process for parenteral biopharmaceuticals) |
| US20060165717A1 (en) | 2005-01-25 | 2006-07-27 | Sanofi Pasteur | DCchol in newborns |
| AR054822A1 (es) | 2005-07-07 | 2007-07-18 | Sanofi Pasteur | Emulsion inmuno adyuvante |
| AU2007226983A1 (en) | 2006-03-20 | 2007-09-27 | Vertex Pharmaceuticals Incorporated | Pharmaceutical compositions |
| MX2009000660A (es) | 2006-07-17 | 2009-04-08 | Glaxosmithkline Biolog Sa | Vacuna de influenza. |
| DE202006018276U1 (de) | 2006-12-01 | 2007-02-08 | Püschner GmbH + Co. KG | Mikrowellen-Vakuumtrockungsanlage zur Trocknung von stückigem, pulverförmigem oder granulatförmigem Gut |
| DE102007055488B4 (de) * | 2006-12-01 | 2015-01-22 | Püschner GmbH + Co. KG | Mikrowellen-Vakuumtrocknungsanlage zur Trocknung von stückigem, pulverförmigem oder granulatförmigem Gut |
| CN101234257B (zh) | 2007-02-01 | 2011-07-27 | 发泰（天津）科技有限公司 | 微波旋转薄膜浓缩器 |
| DE102007012795B3 (de) * | 2007-03-16 | 2008-04-10 | Püschner GmbH + Co. KG | Mikrowellen-Vakuumtrocknungsanlagen und Verfahren zur Trocknung von stückigem, pulverförmigem oder granulatförmigem Gut mittels Mikrowellen |
| EP2101131A1 (en) * | 2007-12-31 | 2009-09-16 | Terruzzi Fercalx S.p.A. | Lyophilization method and system therefor |
| ES2615390T3 (es) | 2008-03-05 | 2017-06-06 | Sanofi Pasteur | Proceso para estabilizar una composición de vacuna que contiene adyuvante |
| EP2578974A1 (en) | 2011-10-05 | 2013-04-10 | Sanofi Pasteur Sa | Process line for the production of freeze-dried particles |
| EP2578975A1 (en) | 2011-10-05 | 2013-04-10 | Sanofi Pasteur Sa | Rotary drum freeze-dryer |
| UA111631C2 (uk) | 2011-10-06 | 2016-05-25 | Санофі Пастер Са | Нагрівальний пристрій для роторної барабанної ліофільної сушарки |
| EP2578976A1 (en) | 2011-10-06 | 2013-04-10 | Sanofi Pasteur Sa | Rotary drum for use in a vacuum freeze-dryer |
-
2011
- 2011-10-05 EP EP11008057.9A patent/EP2578974A1/en not_active Withdrawn
-
2012
- 2012-04-10 UA UAA201404683A patent/UA111858C2/uk unknown
- 2012-04-10 UA UAA201404685A patent/UA111859C2/uk unknown
- 2012-10-04 WO PCT/EP2012/004168 patent/WO2013050162A1/en not_active Ceased
- 2012-10-04 PE PE2014000479A patent/PE20141979A1/es not_active Application Discontinuation
- 2012-10-04 AU AU2012320854A patent/AU2012320854B2/en active Active
- 2012-10-04 MY MYPI2014000743 patent/MY151369A/en unknown
- 2012-10-04 AU AU2012320848A patent/AU2012320848B8/en not_active Ceased
- 2012-10-04 CN CN201280049534.2A patent/CN103917842B/zh active Active
- 2012-10-04 ES ES12769026.1T patent/ES2608478T3/es active Active
- 2012-10-04 HU HUE12769026A patent/HUE029973T2/en unknown
- 2012-10-04 WO PCT/EP2012/004162 patent/WO2013050156A1/en not_active Ceased
- 2012-10-04 PL PL12769021T patent/PL2764309T3/pl unknown
- 2012-10-04 JP JP2014533796A patent/JP5728135B2/ja active Active
- 2012-10-04 EA EA201490719A patent/EA027630B1/ru not_active IP Right Cessation
- 2012-10-04 CA CA2849802A patent/CA2849802C/en not_active Expired - Fee Related
- 2012-10-04 PE PE2014000480A patent/PE20142141A1/es not_active Application Discontinuation
- 2012-10-04 HU HUE12769021A patent/HUE030970T2/en unknown
- 2012-10-04 DK DK12769021.2T patent/DK2764309T3/en active
- 2012-10-04 PH PH1/2014/500617A patent/PH12014500617A1/en unknown
- 2012-10-04 BR BR112014007862-9A patent/BR112014007862B1/pt active IP Right Grant
- 2012-10-04 US US14/348,877 patent/US9920989B2/en active Active
- 2012-10-04 KR KR1020147011244A patent/KR101512608B1/ko active Active
- 2012-10-04 IN IN2407CHN2014 patent/IN2014CN02407A/en unknown
- 2012-10-04 SG SG11201400641QA patent/SG11201400641QA/en unknown
- 2012-10-04 EP EP12769021.2A patent/EP2764309B1/en active Active
- 2012-10-04 CA CA2849799A patent/CA2849799C/en not_active Expired - Fee Related
- 2012-10-04 KR KR1020147011243A patent/KR101552804B1/ko active Active
- 2012-10-04 BR BR112014008001-1A patent/BR112014008001B1/pt active IP Right Grant
- 2012-10-04 JP JP2014533792A patent/JP5766361B2/ja active Active
- 2012-10-04 DK DK12769026.1T patent/DK2766682T3/en active
- 2012-10-04 IN IN2440CHN2014 patent/IN2014CN02440A/en unknown
- 2012-10-04 EA EA201490723A patent/EA027602B1/ru not_active IP Right Cessation
- 2012-10-04 EP EP12769026.1A patent/EP2766682B1/en active Active
- 2012-10-04 US US14/348,869 patent/US10006706B2/en active Active
- 2012-10-04 ES ES12769021.2T patent/ES2608427T3/es active Active
- 2012-10-04 PH PH1/2014/500621A patent/PH12014500621A1/en unknown
- 2012-10-04 CN CN201280049533.8A patent/CN103917841B/zh active Active
- 2012-10-04 MX MX2014004000A patent/MX341894B/es active IP Right Grant
- 2012-10-04 MX MX2014004041A patent/MX359904B/es active IP Right Grant
- 2012-10-04 SG SG11201400640VA patent/SG11201400640VA/en unknown
- 2012-10-04 MY MYPI2014000783 patent/MY152319A/en unknown
- 2012-10-04 EP EP16199831.5A patent/EP3211355A1/en not_active Withdrawn
- 2012-10-04 PL PL12769026T patent/PL2766682T3/pl unknown
-
2014
- 2014-03-17 ZA ZA2014/01930A patent/ZA201401930B/en unknown
- 2014-03-31 IL IL231853A patent/IL231853A0/en unknown
- 2014-03-31 IL IL231849A patent/IL231849A0/en unknown
- 2014-04-04 CO CO14073108A patent/CO6930351A2/es unknown
- 2014-04-04 CO CO14073110A patent/CO6930306A2/es unknown
- 2014-04-04 CR CR20140159A patent/CR20140159A/es unknown
- 2014-04-04 CR CR20140158A patent/CR20140158A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5728135B2 (ja) | 凍結乾燥粒子製造用プロセスライン | |
| CN107073350A (zh) | 用于产生液滴的液体给送装置 | |
| HK1199656B (en) | Process line for the production of freeze-dried particles | |
| HK1200207B (en) | Process, process line and use of the process line for the production of freeze-dried particles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20141029 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20141118 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150212 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20150310 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20150403 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5728135 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |